Redsense Medical AB (publ) (XSAT:REDS)
4.440
+0.340 (8.29%)
At close: Jun 11, 2026
Redsense Medical AB Revenue
Redsense Medical AB had revenue of 6.78M SEK in the quarter ending March 31, 2026, with 38.91% growth. This brings the company's revenue in the last twelve months to 28.70M, down -10.08% year-over-year. In the year 2025, Redsense Medical AB had annual revenue of 26.80M, down -6.84%.
Revenue (ttm)
28.70M
Revenue Growth
-10.08%
P/S Ratio
2.50
Revenue / Employee
5.74M
Employees
5
Market Cap
71.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.80M | -1.97M | -6.84% |
| Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
| Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
| Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
| Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beyond Frames Entertainment AB | 139.93M |
| SolidX AB | 137.67M |
| QBNK Holding AB | 40.29M |
| Aerowash AB | 35.69M |
| Kontigo Care AB | 35.20M |
| Touchtech AB | 23.12M |
| PEPTONIC medical AB | 14.42M |
| Sound Dimension AB | 521.02K |
Redsense Medical AB News
- 24 days ago - Redsense Medical AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Redsense Medical AB Annual report: Q4 2025 - Filings
- 4 months ago - Redsense Medical AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Redsense Medical AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Redsense Medical AB Quarterly report: Q2 2025 - Filings